13
Dec
2019
Immunicum Article in BioStock
Immunicum was recently covered in BioStock’s article, “Immunicum kommenterar vd-bytet” Please note, the article is only available in… Read more
News
13
Dec
2019
RedEye Interview with Michael Oredsson, Chairman of the Board
Chairman of the Board, Michael Oredsson, was interviewed by RedEye this morning in regards to the change… Read more
2
Dec
2019
Immunicum Article in BioStock
Immunicum was recently covered in BioStock’s article, “Immunicum attacks cancer with an immune activation “bomb”” For access to… Read more
24
Oct
2019
Presentation at BioStock Life Science Summit
Our Senior Director Business Development, Sijme Zeilemaker, had the opportunity to present at the BioStock Life Science Summit…. Read more
24
Oct
2019
Immunicum Article in BioStock
Immunicum was recently covered in BioStock’s article, “Positive preclinical results for Immunicum” For access to the full article,… Read more
16
Oct
2019
RedEye Interview with CEO Carlos de Sousa
Our CEO, Carlos de Sousa, was interviewed at RedEye and discussed the Phase II MERECA data and what’s… Read more
16
Oct
2019
Edison Report from 11 October 2019
To access the full report, click here: Full analysis of MERECA top-line results
25
Sep
2019
MERECA Q&A – Swedish
Vilka är de viktigaste resultaten och slutsatserna från MERECA-studien? Top-line data vad gäller överlevnad visar att en… Read more
25
Sep
2019
Webcast Link & Presentation Slides
Link to Webcast Video: https://youtu.be/IqCK8UPW44o Link to Webcast Presentation Slides: 20190925_Webcast Presentation Slides
25
Sep
2019
MERECA Q&A – English
What are the main findings and conclusions from the MERECA study? The topline data on survival benefit… Read more
